chrisvoncsefalvay/vaers-outcomes huggingface dataset:
"mild symptoms including fever"; Pfizer Bivalent - Dose Number: 1; Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022; Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022; This is a spontaneous report received from a contactable reporter(s) (Nurse).  A 44-year-old male patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 04Oct2022 as dose 1, single (Lot number: GJ6742) at the age of 44 years intramuscular, in right arm for covid-19 immunisation; influenza vaccine inact sag 4v (FLUCELVAX QUAD), on 04Oct2022 as dose number unknown, single (Lot number: 942381), in left deltoid for immunisation. The patient didn't receive BNT162b2 (BNT162B2). The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PYREXIA (non-serious) with onset 04Oct2022, outcome "recovered", described as ""mild symptoms including fever""; OFF LABEL USE (non-serious), PRODUCT USE ISSUE (non-serious) all with onset 04Oct2022, outcome "unknown" and all described as "Flucelvax Quad Flu vaccine Seqirus: 04Oct2022 ...Pfizer Bivalent: 04Oct2022"; WRONG PRODUCT ADMINISTERED (non-serious) with onset 04Oct2022, outcome "unknown", described as "Pfizer Bivalent - Dose Number: 1". It was unknown if therapeutic measures were taken as a result of pyrexia.  No follow-up attempts are possible. No further information is expected.; Sender's Comments: Based on known drug safety profile, there is reasonable possibility of causal association between the events and BNT162B2.
UNCONTROLLED LEAKING URINE, CHILLS, FEVER, SEVERE BODY ACHE, THEN CRUSHING CHEST PAIN 4 DAYS AFTER INJECTION
This spontaneous report as received from a nurse refers to a 12 month old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. On 03-JUN-2016, the patient was vaccinated with a dose of M-M-R II (lot #, expiration date, therapy type, dose and site of vaccination were not reported), subcutaneous. Concomitant medication were not reported. On the same day, 5 min after vaccination, the patient experienced hives (reported as "a hive"). The outcome of hives was unknown. The relatedness between the hives and M-M-R II was not reported. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 65 years old patient (gender unknown). The patient was vaccinated with a dose of ZOSTAVAX on approximately  27-NOV-2012 ("about 2 days ago") (lot #, route and dose not reported). No other co-suspects were reported. No concomitant medications were reported. In November 2012, the patient developed 'heat and redness' at the injection site after receiving a dose of ZOSTAVAX. It was unknown if the patient had sought medical attention. No treatment information was reported. The outcome of heat and redness at the injection site is unknown. The relatedness for patient's 'heat and redness' at the injection site was unknown for ZOSTAVAX. Additional information is not expected.
Fever, body aches, chills all started 3/5/2021 and last until 3/7/2021 early morning  Left arm swollen, red rash, warm to the touch and left armpit swollen and tender when touched.  All started 3/5/2021 and is still present 3/8/2021.  Red rash is increasing in size and swelling.   Went to the doctor after calling primary care physician.  Was told to area, take ibuprofen and Benadryl.
This spontaneous report was received from a pharmacist and refers to a female patient of an unknown age. The patient's pertinent medical history, drug reactions or allergies and concomitant medications were not reported. On 13-JUN-2016, the patient was vaccinated with the first dose of VARIVAX injection (route and site of administration, dose, lot number and expiration date were not reported). She did not receive the second dose of the vaccine yet. On an unknown date in 2016 (reported as recently), after receiving VARIVAX, the patient was taking prednisone (manufacturer unknown). The reporter did not know why the patient was on prednisone (manufacturer unknown) therapy and refused to provide any further details about this event. The outcome of the unspecified adverse event, for which the patient was taking prednisone (manufacturer unknown) and the relatedness between this event and the vaccination with VARIVAX were not reported. Additional information has been requested.
SHAKING ALL OVER; PROJECTILE VOMITING; FELL DOWN; ACHING; BAD SHAPE FOR ENTIRE NIGHT; WEAKNESS; SPLITTING HEADACHE; NAUSEA; SPIKE FEVER; This spontaneous report received from a patient concerned a 77 year old female. The patient's height, and weight were not reported. The patient's past medical history included osteoporosis. The patient was previously treated with teriparatide for osteoporosis, varicella zoster vaccine rge (cho), and influenza vaccine. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980, expiry: UNKNOWN) dose was not reported, administered on 30-MAR-2021 14:45 to Right Deltoid for prophylactic vaccination. No concomitant medications were reported. On 30-MAR-2021, the subject experienced shaking all over. On 30-MAR-2021, the subject experienced projectile vomiting. On 30-MAR-2021, the subject experienced fell down. On 30-MAR-2021, the subject experienced aching. On 30-MAR-2021, the subject experienced bad shape for entire night. On 30-MAR-2021, the subject experienced weakness. On 30-MAR-2021, the subject experienced splitting headache. On 30-MAR-2021, the subject experienced nausea. On 30-MAR-2021, the subject experienced spike fever. Laboratory data included: Body temperature (NR: not provided) 104 (units unspecified). On 31-MAR-2021, treatment medications included: diphenhydramine hydrochloride. On 02-APR-2021, Laboratory data included: Body temperature (NR: not provided) 99 (units unspecified). The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from projectile vomiting on 02-APR-2021, had not recovered from nausea, spike fever, and splitting headache, and the outcome of shaking all over, weakness, fell down, aching and bad shape for entire night was not reported. This report was non-serious.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter (Other HCP). The reporter is the patient. A 40-year-old female patient (not pregnant) received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 06Oct2022 as dose 4 (booster), single (Lot number: GJ6739) at the age of 40 years, in left arm for covid-19 immunisation; BNT162b2 (BNT162B2), on 06Apr2021 as dose 1, single (Lot number: EW0150), in left arm, on 27Apr2021 as dose 2, single (Lot number: EW0171), in left arm and on 31Oct2021 as dose 3 (booster), single (Lot number: FF2593), in left arm for covid-19 immunisation.  The patient's relevant medical history included: "Prediabetic" (unspecified if ongoing); "IBS" (unspecified if ongoing); "POCS" (unspecified if ongoing).  The patient's concomitant medications were not reported. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". Therapeutic measures were taken as a result of vaccination failure, covid-19.  Clinical course: the patient was treated with Paxlovid. I tested negative for covid two day after finishing Paxlovid but then tested postitive six days after finishing Paxlovid.; Sender's Comments: Based on the available information in the case, the causal association between the events VACCINATION FAILURE, COVID-19 and the suspect drug BNT162B2 cannot be excluded.
606 doses were given after expiration date; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Nov-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Nov-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (606 doses were given after expiration date) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant drug information was provided.  Reporter stated that the vial did not undergo any temperature excursions. On 01 Mar 2022 the vial was placed in refrigerator. Patient did not experienced any adverse event. No treatment drug information was provided.
PT PRESENTED TO THE PHARMACY ON 08/04/2020 STATING SHE WAS EXPERIENCING SIDE EFFECTS FROM RECEIVING SHINGRIX VACCINE IN RIGHT ARM ON 07/31/2020. PT REPORTED SIDE EFFECTS SYMPTOMS STARTED SECOND DAY AFTER RECEIVING THE VACCINE AND INCREASING WORSEN.  PT STATED HER ARM HURT AND WAS HOT TO TOUCH.  HER ARM DID APPEAR TO BE RED AND SWOLLEN. PT TOOK IBUPROFEN TO HELP WITH THE PAIN.  I RECOMMENDED THE PT CONTINUES TO TAKE IBUPROFEN AND ADD BENADRYL DUE TO AFFECTED AREA STARTING TO ITCH. PT TOLD THIS CAN OCCUR AND WILL REPORT HER SIDE EFFECTS.  I WILL FOLLOW UP WITH PT ON THURSDAY, 08/06/2020.
Finger on left hand was dark(nearly black) on the inside on the palm.; Slightly swollen/ little swollen; Slight pain to touch; First dose on 06Apr2021 and second dose on 20Apr2021; This is a spontaneous report from a contactable consumer, the patient. A 58-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 20Apr2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure, cholesterol, pre diabetic, herpes and known allergies to pollen and etc regular allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included amlodipine (MANUFACTURER UNKNOWN), aciclovir (ACYCLOVIR), acetylsalicylic acid (ASPRIN), metformin (MANUFACTURER UNKNOWN) and losartan (MANUFACTURER UNKNOWN), all for an unknown indication from an unknown date and unknown if ongoing. The patient did not receive any other vaccine within four weeks prior to the COVID-19 vaccine. The patient previously received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 12:00 (at the age of 58-years-old) as a single dose for COVID-19 immunisation. On 23Apr2021 at 06:00, the patient experienced finger on left hand was dark (nearly black) on the inside on the palm. No noticeable pain and appeared slightly swollen. Currently it was PM the finger had somewhat cleared of the darkness except on the inside of the finger still a little swollen and slight pain to touch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events finger on left hand was dark (nearly black) on the inside on the palm. No noticeable pain and appeared slightly swollen, currently it was PM the finger had somewhat cleared of the darkness except on the inside of the finger still a little swollen and slight pain to touch was not recovered at the time of this report.   No follow-up attempts are required; information about lot/batch number cannot be obtained. No further information is expected.
Patient called stating lymph nodes were swollen under neck and under arms. Under eye was a little swollen as well.
Patient came into pharmacy on 12/8/18 to report that the flu vaccine she received on 10/19/18 caused her to become dizzy and light headed for half a day after receiving flu vaccine. She also had nausea and reported "head spinning" feeling the day following flu vaccine. It resolved after 12 hours.
9:20 am Patient was kept under observation for 30 min after the administration of the vaccine.  9:45 am Patient notifies the nurse in charge of the area that he feels itchy forearm, she proceeds to notify the staff, vitals are measured B / P 159/88, P. 68, T. 36.1, R. 21, S. 97 %, Dextrox 91mg / dl. Patient is channeled with .9NS. Starts with rash on both arms and back Dr. of the clinic orders to administer Benadryl 50 mg IV. Patient verbalizes having a heavy tongue and numb left arm and indicates that he cannot breathe.  Benadryl discontinued  O2 cannula is placed. Indicates feeling better. Solumedol IV 125 mg was placed, after the administration began with involuntary movements in the arms and legs. The drug is discontinued. Involuntary movements decreased. She is transported by ambulance by calling 911 to the nearest hospital.
About 20 minutes after getting the shot, my whole face was numb. This lasted almost an hour.
pt recvd vax 18MAR93; on routine exam 29APR93 noted to have gross motor delay, apparently isolated;
I knew that I was exposed to COVID-19 on Sunday from my relative. I was positive. Tuesday night I woke up in the night and my lower leg hurt and it was uncomfortable. It did not last long and had no other symptoms. I called the doctor and they Paxlovid on Wednesday.
Left upper arm red swollen (4.5" by 3"), warm to touch.  Very irritating to client.
CONTACTED AND INFORMED PARENTS  OF THE ISSUE AND GIVEN THE OPTION TO REVACCINATE THEIR CHILD, THEY WERE CONSULTED TO CONTACT THEIR PEDIATRICIAN.
A few days later his arm  hurts. States his arm still hurts when he moves his arm. He is able to move his arm fine.  He feels he can?t move his L arm as well as the r arm now since receiving vaccination.
itched everywhere ears, scalp legs and arms.; headache; tired; itchy nose; This is a spontaneous report from a contactable consumer (patient) A male patient of an unspecified age received BNT162B2 (Solution for injection, Lot/Batch number was not reported) via an unspecified route of administration on 21Jan2021 at single dose for covid-19 immunisation. The patient's medical history and concomitant medications was not reported. The patient received the first vaccine on 21Jan2021. He had a headache, tired and itchy nose. He took a benadryl and it went away. On 25Jan2021 that he itched everywhere ears, scalp legs and arms. The symptoms went away 30 minutes after Benadryl. The patient was not getting any better and maybe a little worse. The outcome of the events was recovered on an unspecified date of 2021.
PATIENT RECEIVED VACCINE FROM OUTSIDE SOURCE PRINZMETAL ANGINA PULMONARY EMBOLISM, UNSPECIFIED. 3/4/2022 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
about 5 hours after the vaccination I started to feel body aches. By the next morning my entire body was in pain. All of my muscles and joints ached and I could barely walk. It's now 3 days later and I'm starting to feel better but my back still aches.
On 2/23/14, patient started to develop swelling behind his ears and neck with a terrible headache. Pt was prescribed prednisone and VALTREX at his doctor's office. Between 3/1 and 3/3 he developed Bell's palsy on his left side of the face. He is not getting any better according to mom but he is on vacation for his spring break.
Was unable to get her second vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history was reported).    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Mar-2021, the patient experienced PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine). On 18-Mar-2021, PRODUCT DOSE OMISSION ISSUE (Was unable to get her second vaccine) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Medical history and concomitant was not provided.   She was scheduled for the second vaccine for March 18, 2021, but was hospitalized for a colon issue and was unable to get her second vaccine.
pt recv vax 16JUN95 & 31JAN96 pt was exposed to chicken pox & devel chicken (bumps all over body; raised papules w/erythematous base;no vesicles);
Information has been received from a consumer concerning his daughter, who was one of seven children in grades 1 and 2 (combined) who reportedly had chickenpox, including her daughter. The reporter noted that her daughter had been previously vaccinated with Varivax on an unspecified date. In December 2006, the daughter developed a papular rash on her face, trunk, back and genitalia, which was confusingly not vesicular, but in different stages. The rash first appeared on her daughter around Christmas. At the time of this report the rash not shown any scabs. His daughter was afebrile, active, and felt perfectly fine otherwise. The reporter communicated she felt that clearly there seems to be some failure of the vaccine suggesting the need for a booster or another wild variant strain not covered by the vaccine. Additional information has been requested.
Patient fully vaccinated with J&J on 4/2/2021 and admitted to the hospital with COVID pneumonia. She was given supportive care and remained stable on 3 to 5 L nasal cannula while hospitalized.  Her main complaint was cough so she was started on Mucinex and her Tessalon Perles was increased. During her hospitalization her oxygen level has been ranging from 3-5 L nasal cannula and clinically has been stable. Mediastinal and hilar lymph node enlargement found on CTA and likely secondary to COVID-19 infection.
Following a band performance on the evening of 3/19/22 while packing up, overcome with lightheadedness and almost fainted.  Symptoms increased to a few times weekly, then daily.  Dizzyness, lightheaded, rapid heart rate. 4/25/22 Blurry vision for an hour and a half in the afternoon Cognitive brain fog, slower processing, unable to recall words 4/26-4/28/22 felt "drunk", dizziness continued, five sick days overall resulting from inability to function
Raised, red, itchy and painful swelling at vaccine site, accompanied by onset of nausea, chills, perspiration, dizziness.
Pt fully vaccinated with the Pfizer vaccine against COVID 19, on 3/7/2021 and 3/28/2021.  Pt tested positive for covid on 9/13/2021.  Presented to our ED on 9/20/2021 and admitted to the hospital.  Found to have COVID-19 bilateral pneumonia, and sepsis.  Still hospitalized.
I was diagnosed by my OBGYN with a UTI and yeast infection, those symptoms arise within a week, and I was diagnosed within 2 weeks after. I was treated with Amoxicillin for the UTI and Monistat 7 for the yeast infection. In both cases some symptoms persisted following the end of those courses of medication. I have a low level of the symptoms of the UTI and they got worse after the second dose. They did a urine test and vaginal culture. 6 weeks after the second dose they did a urine test. The initial vaginal culture and urine test were within 2 weeks of getting the vaccine. My OBGYN recommended taking a cranberry supplement as additional aid for dealing with the UTI. I have done that until recently when I found out it contains something I am allergic to, so I stopped taking it. I had slight brain fog following the first dose and soreness. But following dose 2 I had very intense pain, chills, fever, body aches that began 12 hours after getting the vaccine. Then I had a low level migraine.
In October of 2022 I got COVID-19, my doctor gave my Paxlovid. I got the metallic taste in my mouth that would not go away even after the medication went away. I went to the doctor who looked in my mouth and said that it looked like I may have thrush. I was given medication for the thrush that I started that day. Two days later I had a dental appointment, my dentist said she did not think I had thrush as the medication could not work that fast. I went back to doctor who then agreed that it wasn't thrush but could not find what it was. In November 2022 I was going in for a follow up visit from a procedure I had in the year 2021. I had to have an MRI with and without contrast. It was discovered I had an enlarged liver. I have been diagnosed with NASH.
started w/a high pitch cry; 1 1/2 hrs p/getting shots lasted 18 hrs; pt did sleep 1/2hrs to 45mins & wake up again w/high pitched cry;pt felt very hot, mom did not take temp-did not call MD; spoke w/MD @ time of 4mos vax given DT
Myalgia  fatigue  Narrative:  missed work following second dose due  to symptoms
Patient left exam room after waiting 20 minutes past vaccinations. Medial assistant found patient laying down in front of exit door with mom. Patient was alert and oriented, however, patient pale and reported dizzy, nauseated. Patient ambulated with assistance to exam room. Patient laid down on exam table. Vitals checked. Physician notified. Patient kept an additional 25 mins and physician discharged patient.
COVID vaccine breakthrough case. Moderna 3/7/21 015M20A, 4/5/21 025B21A, and boosted Pfizer 12/1/21 FJ1620
Information has been received from a registered nurse concerning her 23 year old daughter with no pertinent medical history and no known allergies who on 24-JUL-2009 was vaccinated with the first dose of GARDASIL (route and LOT# not reported). On 01-OCT-2009 the patient was vaccinated intramuscularly in left arm with the second 0.5mL dose of GARDASIL (LOT# not reported). On 08-OCT-2009 the patient complained to her mother of neck pain and stiffness, which got worse on 09-OCT-2009. On approximately 12-OCT-2009 the patient had back pain and right arm pain but no fever. The patient also had right side pain and she limited movement of the right arm. The reporter stated that her daughter had been treating herself with TYLENOL and ibuprofen (doses and duration not reported). There was no lab performed. The patient had not recovered at this time of the report. Follow-up information has been received from the physician who indicated that the patient has not contacted. The physician without had any complaints. Additional information is not expected.
Redness of the injection site; Swelling of the injection site; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (Redness of the injection site) and VACCINATION SITE SWELLING (Swelling of the injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 051F21A, 002D21A and 007C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 08-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 09-Nov-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE ERYTHEMA (Redness of the injection site) and VACCINATION SITE SWELLING (Swelling of the injection site). At the time of the report, VACCINATION SITE ERYTHEMA (Redness of the injection site) and VACCINATION SITE SWELLING (Swelling of the injection site) outcome was unknown.            No concomitant medication details was provided. No treatment medication details was provided. Not used anything to alleviate the symptoms.